<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01901419</url>
  </required_header>
  <id_info>
    <org_study_id>TSGHIRB 1-102-05-049</org_study_id>
    <nct_id>NCT01901419</nct_id>
  </id_info>
  <brief_title>Nitroglycerin Infusion During Cardiac Surgery</brief_title>
  <official_title>Nitroglycerin Infusion During Rewarming in Cardiac Surgery and Its Effects on Tissue Perfusion and Coagulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tri-Service General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tri-Service General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothermic cardiopulmonary bypass results in peripheral vasoconstriction and heparin&#xD;
      trapping. Hypoperfusion and ischemic-reperfusion injury are associated with systemic&#xD;
      inflammatory response, while insufficient and delayed neutralization of heparin by protamine&#xD;
      may contribute to more blood loss during rewarming stage.&#xD;
&#xD;
      Nitroglycerin infusion, an NO-related vasodilator, is an established and effective treatment&#xD;
      for unstable angina, myocardial infarction, congestive heart failure, and perioperative&#xD;
      hemodynamic management for cardiac surgery. Therefore, we hypothesize that nitroglycerin&#xD;
      infusion during rewarming corrects systemic ischemic stress and facilitates heparin&#xD;
      neutralization in cardiac surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized clinical trial in a tertiary academic center in patients with cardiac surgery,&#xD;
      to receive either nitroglycerin infusion dose of 0-0.1 mcg/kg/min, or 1-5 mcg/kg/min during&#xD;
      rewarming in cardiopulmonary bypass.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 8, 2013</start_date>
  <completion_date type="Actual">June 8, 2017</completion_date>
  <primary_completion_date type="Actual">June 8, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Lactate Level, Before Incision</measure>
    <time_frame>Before Incision</time_frame>
    <description>Plasma Lactate Level, mmol/L, Before Incision</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Lactate Level, Before Start of CPB</measure>
    <time_frame>Before Start of CPB</time_frame>
    <description>Plasma Lactate Level, mmol/L, Before Start of CPB</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Lactate Level, Release of Aortic Clamp</measure>
    <time_frame>Release of Aortic Clamp</time_frame>
    <description>Plasma Lactate Level, mmol/L, Release of Aortic Clamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Lactate Level, After Protamine Administration</measure>
    <time_frame>After Protamine Administration</time_frame>
    <description>Plasma Lactate Level, mmol/L, After Cessation of CPB and Protamine Administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Lactate Level, Upon Arrival at ICU</measure>
    <time_frame>Upon Arrival at ICU</time_frame>
    <description>Plasma Lactate Level, mmol/L, Upon Arrival at ICU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Glucose Level, Before Incision</measure>
    <time_frame>Before Incision</time_frame>
    <description>Plasma Glucose Level, mg/dL, Before Incision</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Glucose Level, Before Start of CPB</measure>
    <time_frame>Before Start of CPB</time_frame>
    <description>Plasma Glucose Level, mg/dL, Before Start of CPB</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Glucose Level, Release of Aortic Clamp</measure>
    <time_frame>Release of Aortic Clamp</time_frame>
    <description>Plasma Glucose Level, mg/dL, Release of Aortic Clamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Glucose Level, After Protamine Administration</measure>
    <time_frame>After Protamine Administration</time_frame>
    <description>Plasma Glucose Level, mg/dL, After Cessation of CPB and Protamine Administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma Glucose Level, Upon Arrival at ICU</measure>
    <time_frame>Upon Arrival at ICU</time_frame>
    <description>Plasma Glucose Level, mg/dL, Upon Arrival at ICU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion</measure>
    <time_frame>After Initiation of NTG infusion During Rewarming</time_frame>
    <description>Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion During Rewarming of Cardiopulmonary Bypass</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Activated Coagulation Time, Before Start of CPB</measure>
    <time_frame>Before Start of CPB</time_frame>
    <description>Activated Coagulation Time, sec, Before Start of CPB</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activated Coagulation Time, After Protamine Administration</measure>
    <time_frame>After Protamine Administration</time_frame>
    <description>Activated Coagulation Time, sec, After Cessation of CPB and Protamine Administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op Dopamine Infusion</measure>
    <time_frame>Upon Arrival at ICU</time_frame>
    <description>Infusion Rate of Dopamine, mcg/kg/min, Upon Arrival at ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Extubation</measure>
    <time_frame>Arrival at ICU and Extubation</time_frame>
    <description>Time from Arrival at ICU to Extubation, hour</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU Stay</measure>
    <time_frame>Arrival at ICU and Leaving ICU</time_frame>
    <description>Time from Arrival at ICU to Leaving ICU, day</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cardiac Index, Before Start of CPB</measure>
    <time_frame>Before Start of CPB</time_frame>
    <description>Cardiac Index, L/min/m2, Before Start of CPB</description>
  </other_outcome>
  <other_outcome>
    <measure>Cardiac Index, Cessation of CPB</measure>
    <time_frame>Cessation of CPB</time_frame>
    <description>Cardiac Index, L/min/m2, Cessation of CPB</description>
  </other_outcome>
  <other_outcome>
    <measure>Cardiac Index, After Protamine Administration</measure>
    <time_frame>After Protamine Administration</time_frame>
    <description>Cardiac Index, L/min/m2, After Protamine Administration</description>
  </other_outcome>
  <other_outcome>
    <measure>Cardiac Index, Upon Arrival at ICU</measure>
    <time_frame>Upon Arrival at ICU</time_frame>
    <description>Cardiac Index, L/min/m2, Upon Arrival at ICU</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Before Start of CPB, Left Forehead</measure>
    <time_frame>Before Start of CPB</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Before Start of CPB, Left Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Before Start of CPB, Right Forehead</measure>
    <time_frame>Before Start of CPB</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Before Start of CPB, Right Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Beginning Rewarming, Left Forehead</measure>
    <time_frame>Beginning Rewarming</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Beginning Rewarming, Left Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Beginning Rewarming, Right Forehead</measure>
    <time_frame>Beginning Rewarming</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Beginning Rewarming, Right Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Release of Aortic Clamp, Left Forehead</measure>
    <time_frame>Release of Aortic Clamp</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Release of Aortic Clamp, Left Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Release of Aortic Clamp, Right Forehead</measure>
    <time_frame>Release of Aortic Clamp</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Release of Aortic Clamp, Right Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Cessation of CPB, Left Forehead</measure>
    <time_frame>Cessation of CPB</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Cessation of CPB, Left Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, Cessation of CPB, Right Forehead</measure>
    <time_frame>Cessation of CPB</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, Cessation of CPB, Right Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, After Protamine Administration, Left Forehead</measure>
    <time_frame>After Protamine Administration</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, After Protamine Administration, Left Forehead</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebral Oximetry, After Protamine Administration, Right Forehead</measure>
    <time_frame>After Protamine Administration</time_frame>
    <description>Absolute Value of Cerebral Oximetry, %, After Protamine Administration, Right Forehead</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Lactic Acidosis</condition>
  <condition>Blood Glucose, High</condition>
  <arm_group>
    <arm_group_label>High-dose NTG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nitroglycerin infusion 1-5 mcg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-dose NTG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nitroglycerin infusion 0-0.1 mcg/kg/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin infusion</intervention_name>
    <description>Nitroglycerin infusion during rewarming</description>
    <arm_group_label>High-dose NTG</arm_group_label>
    <arm_group_label>Low-dose NTG</arm_group_label>
    <other_name>Millisrol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  elective cardiac surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  heart failure, respiratory failure, asthma attack, uremia, normothermic bypass.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tso-Chou Lin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tri-Service General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tri-Service General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>114</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Piquette D, Deschamps A, Bélisle S, Pellerin M, Levesque S, Tardif JC, Denault AY. Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery. Can J Anaesth. 2007 Sep;54(9):718-27.</citation>
    <PMID>17766739</PMID>
  </reference>
  <reference>
    <citation>Masoumi G, Pour EH, Sadeghpour A, Ziayeefard M, Alavi M, Anbardan SJ, Shirani S. Effect of different dosages of nitroglycerin infusion on arterial blood gas tensions in patients undergoing on- pump coronary artery bypass graft surgery. J Res Med Sci. 2012 Feb;17(2):123-7.</citation>
    <PMID>23264783</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>July 10, 2013</study_first_submitted>
  <study_first_submitted_qc>July 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2013</study_first_posted>
  <results_first_submitted>June 5, 2018</results_first_submitted>
  <results_first_submitted_qc>October 30, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 24, 2020</results_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tri-Service General Hospital</investigator_affiliation>
    <investigator_full_name>Tso-Chou Lin, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>nitroglycerin</keyword>
  <keyword>cardiopulmonary bypass</keyword>
  <keyword>cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Acidosis, Lactic</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all IPD that underlie results in a publication are to be shared starting 6 months after journal publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>starting 6 months after journal publication.</ipd_time_frame>
    <ipd_access_criteria>all IPD that underlie results in a publication are to be shared via email requests. The corresponding author will review requests and send them the supporting information.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 4, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT01901419/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>elective cardiac surgery</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>High-dose NTG</title>
          <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
        </group>
        <group group_id="P2">
          <title>Low-dose NTG</title>
          <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>unavailable researchers</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>High-dose NTG</title>
          <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
        </group>
        <group group_id="B2">
          <title>Low-dose NTG</title>
          <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="63"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>year</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.5" spread="12.2"/>
                    <measurement group_id="B2" value="59.3" spread="13.2"/>
                    <measurement group_id="B3" value="60.9" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plasma Lactate Level</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.1" spread="0.5"/>
                    <measurement group_id="B2" value="1.0" spread="0.4"/>
                    <measurement group_id="B3" value="1.0" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plasma Lactate Level, Before Incision</title>
        <description>Plasma Lactate Level, mmol/L, Before Incision</description>
        <time_frame>Before Incision</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Lactate Level, Before Incision</title>
          <description>Plasma Lactate Level, mmol/L, Before Incision</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.5"/>
                    <measurement group_id="O2" value="1.0" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.618</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Lactate Level, Before Start of CPB</title>
        <description>Plasma Lactate Level, mmol/L, Before Start of CPB</description>
        <time_frame>Before Start of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Lactate Level, Before Start of CPB</title>
          <description>Plasma Lactate Level, mmol/L, Before Start of CPB</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.7"/>
                    <measurement group_id="O2" value="1.6" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.410</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Lactate Level, Release of Aortic Clamp</title>
        <description>Plasma Lactate Level, mmol/L, Release of Aortic Clamp</description>
        <time_frame>Release of Aortic Clamp</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Lactate Level, Release of Aortic Clamp</title>
          <description>Plasma Lactate Level, mmol/L, Release of Aortic Clamp</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.2"/>
                    <measurement group_id="O2" value="2.6" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.088</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Lactate Level, After Protamine Administration</title>
        <description>Plasma Lactate Level, mmol/L, After Cessation of CPB and Protamine Administration</description>
        <time_frame>After Protamine Administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Lactate Level, After Protamine Administration</title>
          <description>Plasma Lactate Level, mmol/L, After Cessation of CPB and Protamine Administration</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.2"/>
                    <measurement group_id="O2" value="3.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.320</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Lactate Level, Upon Arrival at ICU</title>
        <description>Plasma Lactate Level, mmol/L, Upon Arrival at ICU</description>
        <time_frame>Upon Arrival at ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Lactate Level, Upon Arrival at ICU</title>
          <description>Plasma Lactate Level, mmol/L, Upon Arrival at ICU</description>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="1.6"/>
                    <measurement group_id="O2" value="3.2" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.512</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Glucose Level, Before Incision</title>
        <description>Plasma Glucose Level, mg/dL, Before Incision</description>
        <time_frame>Before Incision</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Glucose Level, Before Incision</title>
          <description>Plasma Glucose Level, mg/dL, Before Incision</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.4" spread="47.4"/>
                    <measurement group_id="O2" value="124.2" spread="32.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.144</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Glucose Level, Before Start of CPB</title>
        <description>Plasma Glucose Level, mg/dL, Before Start of CPB</description>
        <time_frame>Before Start of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Glucose Level, Before Start of CPB</title>
          <description>Plasma Glucose Level, mg/dL, Before Start of CPB</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="179.2" spread="62.3"/>
                    <measurement group_id="O2" value="165.7" spread="46.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.338</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Glucose Level, Release of Aortic Clamp</title>
        <description>Plasma Glucose Level, mg/dL, Release of Aortic Clamp</description>
        <time_frame>Release of Aortic Clamp</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Glucose Level, Release of Aortic Clamp</title>
          <description>Plasma Glucose Level, mg/dL, Release of Aortic Clamp</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="174.5" spread="49.5"/>
                    <measurement group_id="O2" value="165.0" spread="29.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.356</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Glucose Level, After Protamine Administration</title>
        <description>Plasma Glucose Level, mg/dL, After Cessation of CPB and Protamine Administration</description>
        <time_frame>After Protamine Administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Glucose Level, After Protamine Administration</title>
          <description>Plasma Glucose Level, mg/dL, After Cessation of CPB and Protamine Administration</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="196.9" spread="53.8"/>
                    <measurement group_id="O2" value="205.7" spread="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.478</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Plasma Glucose Level, Upon Arrival at ICU</title>
        <description>Plasma Glucose Level, mg/dL, Upon Arrival at ICU</description>
        <time_frame>Upon Arrival at ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Glucose Level, Upon Arrival at ICU</title>
          <description>Plasma Glucose Level, mg/dL, Upon Arrival at ICU</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="206.4" spread="55.7"/>
                    <measurement group_id="O2" value="214.8" spread="46.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.515</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion</title>
        <description>Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion During Rewarming of Cardiopulmonary Bypass</description>
        <time_frame>After Initiation of NTG infusion During Rewarming</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion</title>
          <description>Mean Arterial Blood Pressure ≤ 40 mmHg After Initiation of NTG Infusion During Rewarming of Cardiopulmonary Bypass</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Activated Coagulation Time, Before Start of CPB</title>
        <description>Activated Coagulation Time, sec, Before Start of CPB</description>
        <time_frame>Before Start of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Activated Coagulation Time, Before Start of CPB</title>
          <description>Activated Coagulation Time, sec, Before Start of CPB</description>
          <units>second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="158.9" spread="19.8"/>
                    <measurement group_id="O2" value="153.1" spread="18.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.227</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Activated Coagulation Time, After Protamine Administration</title>
        <description>Activated Coagulation Time, sec, After Cessation of CPB and Protamine Administration</description>
        <time_frame>After Protamine Administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Activated Coagulation Time, After Protamine Administration</title>
          <description>Activated Coagulation Time, sec, After Cessation of CPB and Protamine Administration</description>
          <units>second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144.2" spread="15.9"/>
                    <measurement group_id="O2" value="138.2" spread="15.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.141</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-op Dopamine Infusion</title>
        <description>Infusion Rate of Dopamine, mcg/kg/min, Upon Arrival at ICU</description>
        <time_frame>Upon Arrival at ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Post-op Dopamine Infusion</title>
          <description>Infusion Rate of Dopamine, mcg/kg/min, Upon Arrival at ICU</description>
          <units>mcg/kg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="1.8"/>
                    <measurement group_id="O2" value="4.7" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.046</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Extubation</title>
        <description>Time from Arrival at ICU to Extubation, hour</description>
        <time_frame>Arrival at ICU and Extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Extubation</title>
          <description>Time from Arrival at ICU to Extubation, hour</description>
          <units>hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.6" spread="33.7"/>
                    <measurement group_id="O2" value="45.8" spread="34.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.800</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of ICU Stay</title>
        <description>Time from Arrival at ICU to Leaving ICU, day</description>
        <time_frame>Arrival at ICU and Leaving ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Length of ICU Stay</title>
          <description>Time from Arrival at ICU to Leaving ICU, day</description>
          <units>day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="1.8"/>
                    <measurement group_id="O2" value="4.0" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.948</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cardiac Index, Before Start of CPB</title>
        <description>Cardiac Index, L/min/m2, Before Start of CPB</description>
        <time_frame>Before Start of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Index, Before Start of CPB</title>
          <description>Cardiac Index, L/min/m2, Before Start of CPB</description>
          <units>L/min/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.3"/>
                    <measurement group_id="O2" value="2.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.682</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cardiac Index, Cessation of CPB</title>
        <description>Cardiac Index, L/min/m2, Cessation of CPB</description>
        <time_frame>Cessation of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Index, Cessation of CPB</title>
          <description>Cardiac Index, L/min/m2, Cessation of CPB</description>
          <units>L/min/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="1.0"/>
                    <measurement group_id="O2" value="2.7" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.928</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cardiac Index, After Protamine Administration</title>
        <description>Cardiac Index, L/min/m2, After Protamine Administration</description>
        <time_frame>After Protamine Administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Index, After Protamine Administration</title>
          <description>Cardiac Index, L/min/m2, After Protamine Administration</description>
          <units>L/min/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.0"/>
                    <measurement group_id="O2" value="3.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.672</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cardiac Index, Upon Arrival at ICU</title>
        <description>Cardiac Index, L/min/m2, Upon Arrival at ICU</description>
        <time_frame>Upon Arrival at ICU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Index, Upon Arrival at ICU</title>
          <description>Cardiac Index, L/min/m2, Upon Arrival at ICU</description>
          <units>L/min/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="0.9"/>
                    <measurement group_id="O2" value="3.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.894</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Before Start of CPB, Left Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Before Start of CPB, Left Forehead</description>
        <time_frame>Before Start of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Before Start of CPB, Left Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Before Start of CPB, Left Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.4" spread="4.8"/>
                    <measurement group_id="O2" value="76.8" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.135</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Before Start of CPB, Right Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Before Start of CPB, Right Forehead</description>
        <time_frame>Before Start of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Before Start of CPB, Right Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Before Start of CPB, Right Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.9" spread="4.6"/>
                    <measurement group_id="O2" value="77.9" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.038</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Beginning Rewarming, Left Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Beginning Rewarming, Left Forehead</description>
        <time_frame>Beginning Rewarming</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Beginning Rewarming, Left Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Beginning Rewarming, Left Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.0" spread="5.7"/>
                    <measurement group_id="O2" value="68.4" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.852</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Beginning Rewarming, Right Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Beginning Rewarming, Right Forehead</description>
        <time_frame>Beginning Rewarming</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Beginning Rewarming, Right Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Beginning Rewarming, Right Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.9" spread="7.2"/>
                    <measurement group_id="O2" value="69.5" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.454</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Release of Aortic Clamp, Left Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Release of Aortic Clamp, Left Forehead</description>
        <time_frame>Release of Aortic Clamp</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Release of Aortic Clamp, Left Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Release of Aortic Clamp, Left Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.4" spread="5.6"/>
                    <measurement group_id="O2" value="66.8" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.663</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Release of Aortic Clamp, Right Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Release of Aortic Clamp, Right Forehead</description>
        <time_frame>Release of Aortic Clamp</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Release of Aortic Clamp, Right Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Release of Aortic Clamp, Right Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.2" spread="6.1"/>
                    <measurement group_id="O2" value="67.9" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.872</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Cessation of CPB, Left Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Cessation of CPB, Left Forehead</description>
        <time_frame>Cessation of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Cessation of CPB, Left Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Cessation of CPB, Left Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.1" spread="4.0"/>
                    <measurement group_id="O2" value="69.8" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.318</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, Cessation of CPB, Right Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, Cessation of CPB, Right Forehead</description>
        <time_frame>Cessation of CPB</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, Cessation of CPB, Right Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, Cessation of CPB, Right Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.4" spread="4.9"/>
                    <measurement group_id="O2" value="70.0" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.365</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, After Protamine Administration, Left Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, After Protamine Administration, Left Forehead</description>
        <time_frame>After Protamine Administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, After Protamine Administration, Left Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, After Protamine Administration, Left Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.9" spread="4.3"/>
                    <measurement group_id="O2" value="72.1" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.077</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cerebral Oximetry, After Protamine Administration, Right Forehead</title>
        <description>Absolute Value of Cerebral Oximetry, %, After Protamine Administration, Right Forehead</description>
        <time_frame>After Protamine Administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>High-dose NTG</title>
            <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
          <group group_id="O2">
            <title>Low-dose NTG</title>
            <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Oximetry, After Protamine Administration, Right Forehead</title>
          <description>Absolute Value of Cerebral Oximetry, %, After Protamine Administration, Right Forehead</description>
          <units>% of Cerebral Oximetry</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.0" spread="4.7"/>
                    <measurement group_id="O2" value="74.3" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.640</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30-day mortality and complications.</time_frame>
      <desc>Re-sternotomy for bleeding; Mediastinitis with septic shock; Pneumonia; Massive hemothorax</desc>
      <group_list>
        <group group_id="E1">
          <title>High-dose NTG</title>
          <description>Nitroglycerin infusion 1-5 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
        </group>
        <group group_id="E2">
          <title>Low-dose NTG</title>
          <description>Nitroglycerin infusion 0-0.1 mcg/kg/min&#xD;
Nitroglycerin infusion: Nitroglycerin infusion during rewarming</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Mediastinitis with septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Re-sternotomy for bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Massive hemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>One patient in NTG group experienced re-sternotomy to check bleeding in the same day and another one expired at the 25th day postoperatively due to mediastinitis with septic shock.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Tso-Chou Lin</name_or_title>
      <organization>Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan</organization>
      <phone>+886-2-87927128</phone>
      <email>tclin@mail.ndmctsgh.edu.tw</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

